Patrick Hilden
Rutgers, The State University of New Jersey(US)Saint Barnabas Medical Center(US)
Publications by Year
Research Areas
Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Lymphoma Diagnosis and Treatment, Childhood Cancer Survivors' Quality of Life
Most-Cited Works
- → International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)(2017)371 cited
- → A Phase 2 Trial of Stereotactic Radiosurgery Boost After Surgical Resection for Brain Metastases(2013)241 cited
- → Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma(2015)138 cited
- → High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation(2014)121 cited
- → A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma(2014)82 cited
- → Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP53 alterations(2018)71 cited
- → Improved Outcomes With an Enhanced Recovery Approach to Cesarean Delivery(2020)69 cited
- → Big data, machine learning, and artificial intelligence: a field guide for neurosurgeons(2020)57 cited
- → Radiation Dose and Volume to the Pancreas and Subsequent Risk of Diabetes Mellitus: A Report from the Childhood Cancer Survivor Study(2019)51 cited
- → CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse(2015)51 cited